Home » Topics » BioWorld Science

BioWorld Science
RSS

New antifilarials CBR-417 and CBR-490 validated in models in vivo

Aug. 30, 2019

Denali Therapeutics synthesizes brain-penetrant LRRK2 kinase inhibitors for the treatment of PD

Aug. 30, 2019

Mirati Therapeutics compounds target the PRC2 EED binding site

Aug. 30, 2019

La Jolla Pharmaceutical receives European approval for Giapreza

Aug. 30, 2019

Immatics and Celgene collaborate to develop novel adoptive cell therapies

Aug. 30, 2019

First patient enrolled in phase IIa study of sepranolone

Aug. 30, 2019

FDA accepts IND for clinical study of MR-301 for severe traumatic brain injury

Aug. 30, 2019

Pulmonary mucormycosis mouse model developed to test treatments

Aug. 30, 2019

Discovery of a targeted covalent CDK14 inhibitor with a TAIRE kinase-biased selectivity profile

Aug. 30, 2019

Novel Chemerin GPCR agonist OK-113 exhibits anti-inflammatory activity in DED mouse model

Aug. 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...